Business Context and Reporting Period
This Form 8-K Current Report was filed by vTv Therapeutics Inc. on June 21, 2023. The Company is incorporated in Delaware and its Class A common stock (trading symbol: VTVT) is registered on the Nasdaq Capital Market. The report addresses a critical corporate governance event regarding the Company's listing status.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on regulatory compliance regarding stock listing standards rather than financial performance metrics.
Material Changes
- Delisting Notice: On June 21, 2023, the Company received a notice from Nasdaq stating it failed to regain compliance with the minimum closing bid price requirement (Rule 5550(a)(2)) by the June 20, 2023 deadline.
- Trading Suspension: Nasdaq indicated it would suspend trading in the Company's common stock at the opening of business on June 30, 2023, and file a Form 25-NSE to remove the stock from listing.
- Appeal Filed: On June 22, 2023, the Company submitted a request for a hearing to appeal the delisting determination.
- Stay of Action: Nasdaq granted a stay of the delisting action pending a final decision by the Hearings Panel. A hearing is scheduled for August 17, 2023.
Outlook, Risks, and Management Commentary
Management intends to submit a compliance plan to the Hearings Panel as part of the appeal process. The Company will also participate in an expedited review process by submitting a questionnaire regarding its compliance plan by June 29, 2023. The Panel may determine that an oral hearing is unnecessary if the written responses are sufficient to grant an exception.
Risks and Uncertainties: The filing explicitly states there can be no assurance that Nasdaq will accept the Company's compliance plan or that the Company will be able to regain compliance. If the Panel does not grant an exception, the stock will be delisted and trading suspended as originally scheduled.
Investor Verification Checklist
- Verify the current trading status of VTVT on Nasdaq following the June 30, 2023 deadline.
- Monitor the outcome of the Hearings Panel decision scheduled for August 17, 2023.
- Review the Company's submitted compliance plan and questionnaire responses for feasibility.
- Check for subsequent filings regarding the minimum closing bid price and any potential reverse stock splits or other capital structure changes.